DE60143390D1 - Methode zur behandlung von herzinsuffizienz - Google Patents

Methode zur behandlung von herzinsuffizienz

Info

Publication number
DE60143390D1
DE60143390D1 DE60143390T DE60143390T DE60143390D1 DE 60143390 D1 DE60143390 D1 DE 60143390D1 DE 60143390 T DE60143390 T DE 60143390T DE 60143390 T DE60143390 T DE 60143390T DE 60143390 D1 DE60143390 D1 DE 60143390D1
Authority
DE
Germany
Prior art keywords
heart failure
treatment
chf
treat
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60143390T
Other languages
English (en)
Inventor
Irwin Klein
Kaie Ojamaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
North Shore Long Island Jewish Research Institute
Original Assignee
North Shore Long Island Jewish Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North Shore Long Island Jewish Research Institute filed Critical North Shore Long Island Jewish Research Institute
Application granted granted Critical
Publication of DE60143390D1 publication Critical patent/DE60143390D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Medicinal Preparation (AREA)
DE60143390T 2000-03-23 2001-03-16 Methode zur behandlung von herzinsuffizienz Expired - Lifetime DE60143390D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/533,227 US6288117B1 (en) 2000-03-23 2000-03-23 Method for treating congestive heart failure
PCT/US2001/008418 WO2001070218A1 (en) 2000-03-23 2001-03-16 Method for treating congestive heart failure

Publications (1)

Publication Number Publication Date
DE60143390D1 true DE60143390D1 (de) 2010-12-16

Family

ID=24125041

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60143390T Expired - Lifetime DE60143390D1 (de) 2000-03-23 2001-03-16 Methode zur behandlung von herzinsuffizienz

Country Status (11)

Country Link
US (1) US6288117B1 (de)
EP (1) EP1292292B1 (de)
JP (1) JP2003527420A (de)
AT (1) ATE486594T1 (de)
AU (2) AU4578501A (de)
CA (1) CA2403674C (de)
DE (1) DE60143390D1 (de)
IL (2) IL151878A0 (de)
NO (1) NO20024545L (de)
NZ (1) NZ522088A (de)
WO (1) WO2001070218A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040156893A1 (en) * 2003-02-11 2004-08-12 Irwin Klein Method for treating hypothyroidism
GB0525461D0 (en) * 2005-12-15 2006-01-25 Archimedes Dev Ltd Pharmaceutical compositions
US10695309B2 (en) 2017-03-31 2020-06-30 Western New England University Sustained-release liothyronine formulations, method of preparation and method of use thereof
CN111632155B (zh) * 2020-06-01 2023-01-24 西南大学 丝胶-钆pH响应性靶向肿瘤核磁共振造影剂的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3689669A (en) * 1970-10-09 1972-09-05 Univ Of North Carolina The Antidepressant method and composition
US5158978A (en) 1990-02-05 1992-10-27 British Technology Group (U.S.A.) Thyroid hormone treatment of acute cardiovascular compromise
NO924985L (no) * 1991-12-30 1993-07-01 Akzo Nv Thyroaktiv blanding med vedvarende frigjoering

Also Published As

Publication number Publication date
IL151878A (en) 2008-08-07
WO2001070218A1 (en) 2001-09-27
ATE486594T1 (de) 2010-11-15
EP1292292B1 (de) 2010-11-03
NZ522088A (en) 2004-07-30
EP1292292A1 (de) 2003-03-19
CA2403674A1 (en) 2001-09-27
NO20024545L (no) 2002-10-29
NO20024545D0 (no) 2002-09-23
US6288117B1 (en) 2001-09-11
IL151878A0 (en) 2003-04-10
AU4578501A (en) 2001-10-03
JP2003527420A (ja) 2003-09-16
AU2001245785B2 (en) 2005-05-19
CA2403674C (en) 2010-06-08
EP1292292A4 (de) 2006-02-01

Similar Documents

Publication Publication Date Title
MXPA03006855A (es) Metodo para tratar insuficiencia cardiaca cronica y/o niveles elevados de colesterol, utilizando acido 3,5-diyodotiropropionico, y metodo para su preparacion.
DE60101265D1 (de) Behandlung von augenschmerzen
DE60225702D1 (de) Strontium verbindung zur behandlung von sub-dermalem weichteilschmerz
ATE422357T1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
DE60327557D1 (de) Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie
ATE421329T1 (de) Verwendung von aplidine zur behandlung von kardiovaskulären erkrankungen
NO20025405D0 (no) Modulatorer for TNF-alfa-signalisering
DE50209015D1 (de) NEUE VERWENDUNG VON 2-Ä2-Ethoxy-5-(4-methyl-piperazin-1-sulfonyl)-phenylÜ-5-methyl-7-propyl-3H-imidazoÄ5,1-fÜÄ1,2,4Ütriazin-4-on
ATE402699T1 (de) Verwendung von substituierten pyrazolen zur behandlung von allergien
ATE499933T1 (de) Verwendung von betain zur behandlung von claudicatio intermittens
ATE290384T1 (de) Etherlysophospholipide zur behandlung von chronischen entzündlichen erkrankungen
NO20063320L (no) Anvendelse av gaboxadol for behandling av insomni
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
DE60143390D1 (de) Methode zur behandlung von herzinsuffizienz
ATE293972T1 (de) Behandlung von chronischen schmerzen
ATE453386T1 (de) Polyamin-verbindungen zur behandlung von chemokin-rezeptor-vermittelten krankheiten
DE60220825D1 (de) Verwendung von norepinephrinwiederaufnahmehemmern zur behandlung von ticks
ATE536874T1 (de) Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen
ATE354361T1 (de) Neue verwendung von prodigiosin zur behandlung von diabetes mellitus
SE0100873D0 (sv) Method of treatment
DE60128084D1 (de) Verwendung von inaktives cln2 proenzym zur behandlung von lincl
DE60330233D1 (de) Arsentherapie zur behandlung von autoimmunerkrankungen
ATE355063T1 (de) Methode zur behandlung von niereninsuffizienz
ATE291434T1 (de) Verwendung von angiotensin zur behandlung von krebsmetastasierung
DE60226126D1 (de) Verwendung von gamma-gt inhibitoren zur behandlung von chronischen degenerativerkrankungen